Status:
WITHDRAWN
Pilot Study About Safety and Efficacy of Atomized Intrapleural Lidocaine During Pleuroscopy
Lead Sponsor:
Lahey Clinic
Conditions:
Pain
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This study will evaluate the potential to decrease the use of IV anesthesia drugs in patients undergoing pleuroscopy administering lidocane standardly applied to the skin in combination with atomized ...
Detailed Description
Most patient discomfort results from direct manipulation or contact with the parietal pleura during chest tube placement, talc instillation or pleural biopsy. This study intends to use combined IV, in...
Eligibility Criteria
Inclusion
- Patients diagnosed with pleural disease
- Patients undergoing pleuroscopy with talc with or w/o biopsy
- Patients aged 18 - 85
- Patients capable of signing informed consent
Exclusion
- Severe congestive heart failure
- Hepatic failure, bilirubin \> 2mg/dl, ALT,AST 3XULN
- Prior use Lidocaine in 48 hrs
- Hx SA drug reaction to lidocaine or amide local anesthetics
- Second or third degree heart block (w/o pacemaker)
- Sever sinoatrial block (w/o pacemaker)
- Concurrent treatment with quinidine, flecainide, dsopyramide, procainamide (ClassI antirrhythmic agents)
- Prior use or amiodarone hydrochloride
- systolic BP \< 90mmHg
- bradycardia
- accelerated idioventricular rhythm
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00693043
Start Date
February 1 2008
End Date
May 1 2010
Last Update
December 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lahey Clinic
Burlington, Massachusetts, United States, 01805